{"url":"https://lda.senate.gov/api/v1/filings/d4a210e5-f374-45f6-a47c-17a4a6c7231a/","filing_uuid":"d4a210e5-f374-45f6-a47c-17a4a6c7231a","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2021,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/d4a210e5-f374-45f6-a47c-17a4a6c7231a/print/","filing_document_content_type":"text/html","income":"10000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Steven A. Wolfe","dt_posted":"2021-04-20T23:02:20.450000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"5614 Connecticut Avenue, N.W.","registrant_address_2":"#243","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20015","registrant":{"id":308992,"url":"https://lda.senate.gov/api/v1/registrants/308992/","house_registrant_id":38540,"name":"CARDINAL POINT PARTNERS","description":"Government Relations","address_1":"5614 Connecticut Avenue, N.W.","address_2":"#243","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20015","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"BRENT FRANZEL","contact_telephone":"+1 202-664-1111","dt_updated":"2026-01-27T14:05:41.835066-05:00"},"client":{"id":183237,"url":"https://lda.senate.gov/api/v1/clients/183237/","client_id":1005053,"name":"TONIX PHARMACEUTICALS, INC.","general_description":"biotechnology company--pharmaceuticals development and manufacturing","client_government_entity":false,"client_self_select":null,"state":"NJ","state_display":"New Jersey","country":"US","country_display":"United States of America","ppb_state":"NJ","ppb_state_display":"New Jersey","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2017-01-17"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Funding for pandemic response research and development funding in HR 1219 The American Rescue Plan Act of 2021","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":40868,"prefix":null,"prefix_display":null,"first_name":"STEVEN","nickname":null,"middle_name":"A","last_name":"WOLFE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}